申请人:Tularik Inc.
公开号:US20030220339A1
公开(公告)日:2003-11-27
Heterocyclic arylsulfonamidobenzylic compounds are provided which are useful in treating lipid disorders, metabolic disorders and cell-proliferative diseases.
提供了杂环芳基磺酰胺基苯基化合物,可用于治疗脂质紊乱、代谢紊乱和细胞增殖性疾病。